Balchem logo

BCPC - Balchem Share Price

$117.83 -0.3  -0.2%

Last Trade - 22/01/21

Consumer Defensives
Large Cap
Market Cap £2.79bn
Enterprise Value £2.87bn
Revenue £503.8m
Position in Universe 1585th / 6630
Unlock BCPC Revenue
Relative Strength (%)
1m +0.11%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
541.4 552.5 553.2 594.8 643.7 643.7 699.3 737.1 +3.5%
+17.5 +10.9 -5.8 +14.3 +18.9 +4.5 +30.5 +2.36
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, BalchemCorporation revenues increased 10% to $522.9M. Net incomeincreased 5% to $62.5M. Revenues reflect Human nutrition &health segment increase of 15% to $296.5M, Animal Nutrition& Health segment increase of 9% to $141.3M, United Statessegment increase of 8% to $380.5M, Foreign Countriessegment increase of 15% to $142.5M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BCPC
Graphical History


BCPC Revenue Unlock BCPC Revenue

Net Income

BCPC Net Income Unlock BCPC Revenue

Normalised EPS

BCPC Normalised EPS Unlock BCPC Revenue

PE Ratio Range

BCPC PE Ratio Range Unlock BCPC Revenue

Dividend Yield Range

BCPC Dividend Yield Range Unlock BCPC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BCPC EPS Forecasts Unlock BCPC Revenue
Profile Summary

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, providing solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems. The Animal Nutrition & Health segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry. The Industrial Products segment includes the manufacture and sale of methylamines.

Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated January 30, 1967
Public Since June 3, 1986
No. of Shareholders: 73
No. of Employees: 1,424
Sector Consumer Defensives
Industry Food & Tobacco
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 32,351,112
Free Float (0.0%)
Eligible for
BCPC Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BCPC
Upcoming Events for BCPC
Friday 19th February, 2021 Estimate
Q4 2020 Balchem Corp Earnings Release
Thursday 29th April, 2021 Estimate
Q1 2021 Balchem Corp Earnings Release
Frequently Asked Questions for Balchem
What is the Balchem share price?

As of 22/01/21, shares in Balchem are trading at $117.83, giving the company a market capitalisation of £2.79bn. This share price information is delayed by 15 minutes.

How has the Balchem share price performed this year?

Shares in Balchem are currently trading at $117.83 and the price has moved by 9.21% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Balchem price has moved by -6.59% over the past year.

What are the analyst and broker recommendations for Balchem?

Of the analysts with advisory recommendations for Balchem, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Balchem is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Balchem next release its financial results?

Balchem is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Balchem dividend yield?

The Balchem dividend yield is 0.44% based on the trailing twelve month period.

Does Balchem pay a dividend?

Last year, Balchem paid a total dividend of 0.52, and it currently has a trailing dividend yield of 0.44%. Looking ahead, Balchem has not announced an ex-dividend date yet.

When does Balchem next pay dividends?

Balchem has yet to annouce their ex-dividend date. The historic dividend yield on Balchem shares is currently 0.44%.

How do I buy Balchem shares?

To buy shares in Balchem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Balchem?

Shares in Balchem are currently trading at $117.83, giving the company a market capitalisation of £2.79bn.

Where are Balchem shares listed? Where are Balchem shares listed?

Here are the trading details for Balchem:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: BCPC
What kind of share is Balchem?

Based on an overall assessment of its quality, value and momentum, Balchem is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Balchem share price forecast 2021?

Shares in Balchem are currently priced at $117.83. At that level they are trading at 0.07% premium to the analyst consensus target price of 0.00.

Analysts covering Balchem currently have a consensus Earnings Per Share (EPS) forecast of 3.307 for the next financial year.

How can I tell whether the Balchem share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Balchem. Over the past six months, the relative strength of its shares against the market has been 0.87%. At the current price of $117.83, shares in Balchem are trading at 16.91% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Balchem PE Ratio?

The Balchem PE ratio based on its reported earnings over the past 12 months is 44.84. The shares are currently trading at $117.83.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Balchem?

Balchem's management team is headed by:

John Televantos - LED
Paul Coombs - IND
David Fischer - IND
William Backus - CAO
Theodore Harris - CHM
Daniel Knutson - IND
Mark Stach - GCN
Martin Bengtsson - CFO
Scott Mason - VPR
Joyce Lee - IND
Who are the major shareholders of Balchem?

Here are the top five shareholders of Balchem based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 13.67% (4.42m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.84% (3.51m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 6.42% (2.08m shares)
Brown Capital Management, LLC Investment Advisor
Percentage owned: 4.37% (1.41m shares)
Fred Alger Management, LLC Investment Advisor/Hedge Fund
Percentage owned: 3.12% (1.01m shares)
Similar to BCPC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.